AC
KURA icon

Athanor Capital’s Kura Oncology KURA Stock Holding History

Athanor Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16,289
Closed -$532K – 946
2020
Q4 		$532K Sell
16,289
-4,129
-20% -$145K 0.01% 455
2020
Q3 		$626K Sell
20,418
-7,895
-28% -$174K 0.02% 299
2020
Q2 		$462K Buy
+28,313
New +$408K 0.02% 320
2020
Q1 		– Sell
-20,607
Closed -$283K – 254
2019
Q4 		$283K Sell
20,607
-8,693
-30% -$129K 0.01% 318
2019
Q3 		$444K Buy
29,300
+9,300
+47% +$166K 0.03% 165
2019
Q2 		$394K Buy
+20,000
New +$332K 0.05% 102

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Athanor Capital's KURA Position: Q1 2021 in Review

Athanor Capital sold out of Kura Oncology (KURA) in Q1 2021, closing a stake of 16,289 shares — an estimated $532K sold.

Athanor Capital first reported a position in KURA in Q2 2019 and held it in 6 quarters. The position peaked at $626K in Q3 2020. 171 funds tracked by Wall St. Rank hold KURA as of Q1 2021.

  • Athanor Capital reported no remaining Kura Oncology position as of Q1 2021 after selling out during the quarter.
  • Athanor Capital sold 16,289 Kura Oncology shares in Q1 2021, an estimated $532K.
  • Athanor Capital first reported a position in Kura Oncology in Q2 2019 and held it in 6 quarters.
  • Athanor Capital's Kura Oncology position peaked at $626K in Q3 2020.
  • 171 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2021.

Based on Athanor Capital's 13F filing for Q1 2021, filed 14 May 2021.